Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Original Research

Published on 19 Mar 2024

Dapagliflozin versus sacubitril–valsartan for heart failure with mildly reduced or preserved ejection fraction

in Drugs Outcomes Research and Policies

Ronen Arbel
Abed N. Azab
Mansi Oberoi
Enis Aboalhasan
Artyom Star
Khaled Elhaj
Fouad Khalil
Hilmi Alnsasra

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1357673

3,036 views
1 citation

Original Research

Published on 18 Mar 2024

Assessment of the implementation of accelerated drug marketing registration procedures for antineoplastic and immunomodulating agents in China: based on 2016–2022 review data

in Drugs Outcomes Research and Policies

Yipeng Lan
Xiaofeng Lin
Jialin Yu
Li Wang
Lihua Sun
Zhe Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1345672

1,681 views
2 citations

Original Research

Published on 18 Mar 2024

Examining the safety of mirabegron: an analysis of real-world pharmacovigilance data from the US FDA adverse event reporting system (FAERS) database

in Drugs Outcomes Research and Policies

Junwei Wang
Aiwei Zhang
Miaoyong Ye
Cunming Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1376535

5,384 views
5 citations

Original Research

Published on 13 Mar 2024

Impact of treatment adherence and inhalation technique on asthma outcomes of pediatric patients: a longitudinal study

in Drugs Outcomes Research and Policies

Catalina Lizano-Barrantes
Olatz Garin
Karina Mayoral
Alexandra L. Dima
Angels Pont
María Araceli Caballero-Rabasco
Manuel Praena-Crespo
Laura Valdesoiro-Navarrete
María Teresa Guerra
Alberto Bercedo-Sanz

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1340255

3,102 views
2 citations

Original Research

Published on 12 Mar 2024

The Prescription trends and dosing appropriateness analysis of novel oral anticoagulants in ischemic stroke patients: a retrospective study of 9 cities in China

in Drugs Outcomes Research and Policies

Mingfen Wu
Hailun Jiang
Kefu Yu
Zhigang Zhao
Bin Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1304139

1,464 views
1 citation

Original Research

Published on 12 Mar 2024

A real-world disproportionality analysis of Everolimus: data mining of the public version of FDA adverse event reporting system

in Drugs Outcomes Research and Policies

Bin Zhao
Yumei Fu
Shichao Cui
Xiangning Chen
Shu Liu
Lan Luo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1333662

3,271 views
13 citations

Original Research

Published on 11 Mar 2024

Pharmacological treatments and medication-related problems in nursing homes in Catalonia: a multidisciplinary approach

in Drugs Outcomes Research and Policies

Emilie Anderssen-Nordahl
Margarita Sánchez-Arcilla Rosanas
Montserrat Bosch Ferrer
Mònica Sabaté Gallego
Eladio Fernández-Liz
Antonio San-José
Maria Estrella Barceló-Colomer

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1320490

2,195 views
2 citations

Systematic Review

Published on 08 Mar 2024

Efficacy and safety of levosimendan in patients with sepsis: a systematic review and network meta-analysis

in Drugs Outcomes Research and Policies

Ruimin Tan
He Guo
Zinan Yang
Huihui Yang
Qinghao Li
Qiong Zhu
Quansheng Du

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1358735

3,132 views
2 citations

Original Research

Published on 08 Mar 2024

Clinical aspects of reimbursement policies for orphan drugs in Central and Eastern European countries

in Drugs Outcomes Research and Policies

Szczepan Jakubowski
Pawel Kawalec
Przemyslaw Holko
Iwona Kowalska-Bobko
Maria Kamusheva
Guenka Petrova
Pero Draganić
Leos Fuksa
Agnes Männik
Fanni Ispán

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1369178

2,920 views
3 citations

Review

Published on 07 Mar 2024

Ferric citrate for the treatment of hyperphosphatemia and iron deficiency anaemia in patients with NDD-CKD: a systematic review and meta-analysis

in Drugs Outcomes Research and Policies

Xueying Ding
Shujie Sun
Jinjin Zhang
Huifang Zhao
Fenglan Lun
Xuemin Liu
Yiwan Zhen
Jinping Dong
Jingliang Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1285012

3,367 views
3 citations

Original Research

Published on 07 Mar 2024

Validity and reliability of the Romanian version of the Hill-Bone compliance to high blood pressure therapy scale

in Drugs Outcomes Research and Policies

Răzvan-Nicolae Rusu
Radu Sebastian Gavril
Daniela Carmen Ababei
Ioana Macadan
Andrei Ciobîcă
Camelia Nicolae
Răducu Ionuț Popescu
Walther Bild
Veronica Bild

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1256848

1,695 views
2 citations

Brief Research Report

Published on 23 Feb 2024

Prevalence of inappropriateness of elemene injection for hospitalized cancer patients: a multicenter retrospective study

in Drugs Outcomes Research and Policies

Mingzheng Cen
Guojun Jiang
Yuhua Zhao
Zhenwei Yu
Minxian Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1334701

844 views

Original Research

Published on 23 Feb 2024

Digging in real-word electronic database for assessing CDK 4/6 inhibitors adherence in breast cancer patients from Romania

in Drugs Outcomes Research and Policies

Adina Turcu-Stiolica
Ion Udristoiu
Mihaela-Simona Subtirelu
Victor Gheorman
Madalina Aldea
Elena Adriana Dumitrescu
Simona Ruxandra Volovat
Dragos Mircea Median
Cristian Virgil Lungulescu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1345482

2,485 views
4 citations

Original Research

Published on 20 Feb 2024

The characteristics and operations of “online pharmacies” investigated in relation to medicines popularised during the coronavirus pandemic: a cross-sectional study

in Drugs Outcomes Research and Policies

Oria Jason Oriakhi
Hamzeh Almomani
Nilesh Patel
Parastou Donyai

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1346604

6,041 views
1 citation

Original Research

Published on 16 Feb 2024

Evaluation of medication safety assessment tools for pharmacist-led medication reviews: the Eastern European pilot project

in Drugs Outcomes Research and Policies

Anita Tuula
Piotr Merks
Magdalena Waszyk-Nowaczyk
Mariola Drozd
Galina Petrova
Reka Viola
Veera Bobrova
Michael Scott
Marje Oona
Daisy Volmer

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1348400

2,976 views
2 citations

Original Research

Published on 14 Feb 2024

The impact of level of documentation on the accessibility and affordability of new drugs in Norway

in Drugs Outcomes Research and Policies

Gro Live Fagereng
Anne Marit Morvik
Sara Reinvik Ulimoen
Anne Marthe Ringerud
Iselin Dahlen Syversen
Erik Sagdahl

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1338541

2,454 views
1 citation